Latest Asx News

Tartana Minerals revises its corporate presentation to clarify prior disclosures while spotlighting a $4.5 million capital raise to boost copper sulphate production and expand drilling across its Far North Queensland portfolio.

Legacy Minerals has withdrawn its earlier Mt Carrington production targets, updating its Scoping Study to reflect a stronger basis with 71% Indicated Resources. The revised study outlines a 12-year mine life, A$514 million pre-tax NPV7, and a streamlined development plan.

Diamond Infraco, backed by IFM Global Infrastructure Fund, has lodged a Takeovers Panel application alleging material disclosure deficiencies in Atlas Arteria's takeover bid documents, centering on governance rights tied to the Chicago Skyway asset.

National Australia Bank has updated its dividend details for the half-year ending March 2026, maintaining an 85 cent fully franked payout and expanding currency payment options to include AUD, GBP, NZD, and USD.

Zimi Limited has increased its placement commitments by A$100,000 from a sophisticated investor, bringing total funds raised to A$1.56 million ahead of shareholder approval.

Ballymore Resources launches a $3.24 million pro-rata entitlement offer priced at 12.5 cents per share, sweetened with free attaching options exercisable at 22 cents, to fund ongoing Queensland exploration and development.

The Supreme Court of Western Australia has approved the acquisition of Winsome Resources by Li-FT Power, triggering the legal effectiveness of the share and option schemes. Winsome shares will suspend trading on the ASX from 12 May 2026, with key implementation and delisting dates set for later this month.

Peel Mining has formally moved forward in its acquisition by Aeris Resources with the dispatch of the Scheme Booklet to shareholders, setting the stage for critical meetings on June 15.

Diablo Resources has completed the first tranche of a placement, raising $764,400 through 58.8 million shares at 1.3 cents each, with a shareholder meeting planned in June to approve a further $2.7 million raise.

The Asian Development Bank ramped up its commitments to $29.3 billion in 2025, driving private sector growth, regional cooperation, and climate resilience across Asia and the Pacific.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

Magontec Limited reported a robust first quarter in 2026, with gross profit surging 63% and metals sales volumes up 58%, driven by margin improvements and strategic expansion in electronic anodes and magnesium alloys.